[go: up one dir, main page]

WO2018175386A1 - Compositions polyamide comprenant un polymère thermoplastique - Google Patents

Compositions polyamide comprenant un polymère thermoplastique Download PDF

Info

Publication number
WO2018175386A1
WO2018175386A1 PCT/US2018/023273 US2018023273W WO2018175386A1 WO 2018175386 A1 WO2018175386 A1 WO 2018175386A1 US 2018023273 W US2018023273 W US 2018023273W WO 2018175386 A1 WO2018175386 A1 WO 2018175386A1
Authority
WO
WIPO (PCT)
Prior art keywords
polyamide composition
polyamide
thermoplastic polymer
ether
poly
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2018/023273
Other languages
English (en)
Inventor
Alan James Lesser
Md Arifur RAHMAN
Philippe Desbois
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BASF SE
University of Massachusetts Boston
University of Massachusetts Amherst
Original Assignee
BASF SE
University of Massachusetts Boston
University of Massachusetts Amherst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BASF SE, University of Massachusetts Boston, University of Massachusetts Amherst filed Critical BASF SE
Publication of WO2018175386A1 publication Critical patent/WO2018175386A1/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L77/00—Compositions of polyamides obtained by reactions forming a carboxylic amide link in the main chain; Compositions of derivatives of such polymers
    • C08L77/02—Polyamides derived from omega-amino carboxylic acids or from lactams thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G69/00—Macromolecular compounds obtained by reactions forming a carboxylic amide link in the main chain of the macromolecule
    • C08G69/02—Polyamides derived from amino-carboxylic acids or from polyamines and polycarboxylic acids
    • C08G69/08—Polyamides derived from amino-carboxylic acids or from polyamines and polycarboxylic acids derived from amino-carboxylic acids
    • C08G69/14—Lactams
    • C08G69/16—Preparatory processes
    • C08G69/18—Anionic polymerisation

Definitions

  • Polyamides are widely known for their high impact resistance, good toughness, abrasion resistance, and strength, where the crystallinity and crystal structure play an important role in determining these properties.
  • polyamides are generally synthesized by the ring-opening polymerization of a cyclic lactam monomer, such as ⁇ - caprolactam, by hydrolysis, a process requiring multiple steps, making the hydrolysis method unsuitable for injection molding.
  • a cyclic lactam monomer such as ⁇ - caprolactam
  • anionic polymerization of cyclic lactam monomers can be very effective for reaction injection molding due to the fast reaction kinetics of the polymerization and the formation of little to no by-products.
  • shrinkage can result in dimensional instability, for example, by as much as 10 to 20% and can ultimately result in article failure.
  • methods have been considered to reduce the shrinkage of anionically polymerized polyamides, they generally include a melt mixing step, which results in a reduction in the crystallinity of the polyamide and ultimately in a reduction of the mechanical properties.
  • a polyamide composition comprising a thermoplastic polymer and a method of making the same.
  • a polyamide composition comprises an anionically polymerized polyamide; and a thermoplastic polymer.
  • a Hildebrand solubility factor of the anionically polymerized polyamide can be within 15% of a Hildebrand solubility factor of the thermoplastic polymer.
  • a method of making a polyamide composition comprises anionically polymerizing a monomer mixture comprising a cyclic lactam monomer, a thermoplastic polymer, a catalyst, and an activator to form the polyamide composition.
  • FIG. 1 is a scanning electron microscopy image of the composition of Example 2;
  • FIG. 2 is a scanning electron microscopy image of the composition of Example 4.
  • FIG. 3 is a scanning electron microscopy image of the composition of Example 7;
  • FIG. 4 is a scanning electron microscopy image of the composition of Example 10.
  • FIG. 5 is a graphical illustration of the differential scanning calorimetry scans of Examples 1, 7, 8, and 9;
  • FIG. 6 is a graphical illustration of the differential scanning calorimetry scans of Examples 1, 10, 11, and 12;
  • FIG. 7 is a graphical illustration of the thermogravimetric analysis of Examples 1, 7, 8, and 9;
  • FIG. 8 is a graphical illustration of the thermogravimetric analysis of Examples 1, 10, 11, and 12.
  • FIG. 9 is a graphical illustration of the linear expansion of Examples 1, 8, and 10 with temperature.
  • shrinkage arises not only from the inherent densification due to the formation of covalent bonds between the monomers, but also to the fact that the polymerization is generally performed at or below the crystallization temperature of polyamide, so the material crystallizes as it polymerizes and also from thermal contraction of the polyamide during post-polymerization cooling.
  • the method comprises anionically polymerizing a monomer mixture comprising a cyclic lactam monomer, the thermoplastic polymer, a catalyst, and an activator to form the polyamide composition.
  • a Hildebrand solubility factor of the anionically polymerized polyamide can be within 10%, or within 5% of a Hildebrand solubility factor of the thermoplastic polymer.
  • the anionically polymerized polyamide comprises polyamide 6 having a Hildebrand solubility parameter of 22.5 Joules to the 1/2 times centimeters to the - 3/2 (J 1/2 cm “ /2 )
  • the Hildebrand solubility parameter of the thermoplastic polymer can be 20.2 to 24.8 J 1/2 cm “ /2 , or 21.3 to 23.6 J 1/2 cm “ /2 .
  • a Hildebrand solubility factor of the anionically polymerized polyamide can be within 30%, or within 15% of a Hildebrand solubility factor of the thermoplastic polymer.
  • the Hildebrand solubility factor of the thermoplastic polymer and the anionically polymerized polyamide can each independently be greater than or equal to 19 J 1/2 cm “ /2 , or greater than or equal to 20 J 1/2 cm “ /2 , or 19 to 25 J 1/2 cm “ /2 , or 20 to 24 j i /2 cm -3/2 thermoplastic polymer can be free of (such that it can include 0 to 0.01 wt%) of a poly(methyl methacrylate) having a Hildebrand solubility factor of 18.6 J 1/2 cm " /2 .
  • thermoplastic polymer has a Hildebrand solubility factor that is significantly different from that of the anionically polymerized polyamide, then the polyamide composition can display phase separation.
  • polystyrene can be considered miscible in some cyclic lactam monomers
  • solubility of the polystyrene decreases in the polymerized polyamide, which can result in a significant amount of phase separation exhibiting large polystyrene domains embedded in the polyamide.
  • the polyamide composition comprises an anionically polymerized polyamide and a thermoplastic polymer.
  • the polyamide composition can comprise 5 to 50 weight percent (wt%), or 10 to 30 wt% of the thermoplastic polymer based on a total weight of the polyamide composition.
  • the anionically polymerized polyamide can have a weight average molecular weight of 2,000 to 100,000 Daltons (Da), or 5,000 to 50,000 Da as measured by gel permeation chromatography based on polystyrene standards.
  • the polyamide composition can have a crystallinity of 20 to 45 wt%, or 20 to 40 wt%, or 25 to 35 wt%, or 35 to 40 wt% as determined by differential scanning calorimetry (DSC).
  • DSC differential scanning calorimetry
  • a polyamide composition having a size of 4.5 ⁇ 0.1 milligram (mg) is sealed in a closed hermetic aluminum pan and heated at a heating rate of 10 degrees Celsius per minute (°C/min) over a temperature range of -20 to 250 degrees Celsius (°C).
  • the weight percent crystallinity (X c ) is then determined by dividing the change in enthalpy of the polyamide composition measure from the DSC scan (AH m ) by the change in enthalpy of a 100 wt% crystalline sample of the same polyamide (AH C ) as shown in Equation (I).
  • the polyamide composition can have a coefficient of linear thermal expansion (CLTE) as compared to a corresponding polyamide composition formed in the absence of a thermoplastic polymer.
  • CLTE coefficient of linear thermal expansion
  • the polyamide composition can have a coefficient of linear thermal expansion of less than 110x10 "5 inverse degrees Celsius (°C _1 ), or less than or equal to 108xl0 "5 °C- or 60x10 "5 to 108xl0 "5 °0 or 60x10 "5 to 105 xlO "5 ° ⁇ ⁇ .
  • the coefficient of linear thermal expansion can be determined by forming a cylindrical sample having a 6 millimeter (mm) diameter and a 10 mm height and testing the samples in dynamic
  • thermomechanical analysis (TMA) mode at a heating rate of 5 °C/min over the temperature range of 30 to 150 °C.
  • An average value of CLTE (a) over a temperature range of 30 to 150 °C is given using Equation (II)
  • Equation (II) / is the length at 30 °C, // is the length at Ti (30 °C) and h is the length at T2 (45 °C).
  • a method of making the polyamide composition can comprise anionically polymerizing a monomer mixture comprising a cyclic lactam monomer, the thermoplastic polymer, a catalyst, and an activator to form the polyamide composition.
  • the monomer mixture can further comprise a catalyst and an initiator.
  • the polymerizing can comprise melt polymerizing at a temperature of greater than or equal to the melting temperature of the cyclic lactam monomer and below the melting point of the polymerizing polyamide.
  • the melt polymerizing can occur at a temperature of 25 to 70 °C, or 80 to 220 °C, or 100 to 200 °C, or 145 to 165 °C.
  • the melt polymerizing can occur at a temperature of less than or equal to 190 °C.
  • the melt polymerizing can occur at a temperature of 100 to 220 °C, or 145 to 165 °C.
  • the thermoplastic polymer can be soluble in the cyclic lactam monomer.
  • the thermoplastic polymer can be considered soluble in the cyclic lactam monomer if a monomer mixture comprising at least the cyclic lactam monomer and the thermoplastic polymer can comprise greater than 0 to 50 wt% of the dissolved thermoplastic polymer based on the total weight of the monomer mixture at 23 °C.
  • the thermoplastic polymer can comprise a polyether such as a poly(ether imide) (PEI), a poly( ether ketone) (PEK), a poly(ether ether ketone) (PEEK), a poly(ether ketone ketone) (PEKK), a poly(ether sulfone), a poly(ether ether sulfone) (PEES), or a combination comprising at least one of the foregoing.
  • the thermoplastic polymer can comprise poly(ether imide), poly(ether ether sulfone), or a combination comprising at least one of the foregoing.
  • poly(ether imide) and poly(ether ether sulfone) in the polyamide composition can beneficially result in one or both of a reduction in water absorption of the polyamide composition and an increase flame retardancy as compared to a corresponding polyamide composition formed in the absence of the thermoplastic polymer.
  • the thermoplastic polymer can comprise a copolymerizable repeat unit that is polymerizable with the cyclic lactam monomer.
  • the thermoplastic polymer can comprise 0 to 5 mole percent (mol%) of a repeat unit that is polymerizable with the cyclic lactam monomer based on the total moles of repeat units of the thermoplastic polymer.
  • the presence of a copolymerizable repeat unit can result in a cross-linking between the thermoplastic polymer and the polyamide.
  • the polyamide composition can further comprise an additional polymer.
  • the additional polymer can be present with the thermoplastic polymer during the polymerization of the cyclic lactam monomer.
  • the additional polymer can be at least partially soluble in the cyclic lactam monomer.
  • the additional polymer can comprise a polyacetal, a polyolefin, a polyacrylic, a polycarbonate, a polystyrene (PS), a polyester, a second polyamide, a polyamideimide, a polyarylate, a polyarylsulfone, a polyphenylene sulfide, a polyvinyl chloride, a polysulfone, a polyimide, a polyfluoroethylene, a polybenzoxazole, a polyphthalide, a polyacetal, a polyanhydride, a polyvinyl ether, a polyvinyl thioether, a polyvinyl alcohol, a polyvinyl ketone, a polyvinyl halide, a polyvinyl nitrile, a polyvinyl ester, a polysulfonate, a polysulfide, a polythioester, a polysulfone, a polysulf
  • the polyamide composition can comprise a copolymerized siloxane that is polymerized simultaneously with the polyamide.
  • the copolymerized siloxane can be derived from octaphenylcyclotetrasiloxane.
  • the cyclic lactam monomer can comprise greater than or equal to 3 carbon atoms, or 3 to 14 carbon atoms, or 5 to 10 carbon atoms in the lactam ring.
  • the cyclic lactam monomer can comprise ⁇ -propiolactam (also known as 2-azetidinone), ⁇ -butyrolactam (also known as 2-pyrrolidone), ⁇ -valerolactam (also known as 2-piperidine), ⁇ -caprolactam, enantholactam, caprylolactam, laurolactam, ⁇ , ⁇ -dimethylpropiolactam, ⁇ , ⁇ - dimethylpropiolactam, amylolactam, or a combination comprising at least one of the foregoing.
  • the cyclic lactam monomer can comprise an alkyl substituted cyclic lactam, an aryl substituted cyclic lactam, or a combination comprising at least one of the foregoing.
  • the cyclic lactam monomer can comprise ⁇ -caprolactam.
  • the cyclic lactam monomer can comprise a combination comprising at least one of the foregoing cyclic lactam monomers.
  • the monomer mixture can comprise a catalyst.
  • the catalyst can comprise an iminium salt that can be prepared by reacting a base with a lactam such as the cyclic lactam monomer.
  • a lactam such as the cyclic lactam monomer.
  • the cyclic lactam monomer to be polymerized can be used for the preparation of the catalyst; but the catalyst can likewise be prepared from a different lactam.
  • the iminium salt can be prepared by reacting the lactam with a metal compound.
  • the metal compound can comprise a metal, a basic derivative of the metal, or a combination comprising at least one of the foregoing.
  • the metal can comprise an alkali metal (such as sodium and potassium), an alkaline earth metal (such as magnesium), aluminum, or a combination comprising at least one of the foregoing.
  • the basic derivative of the metal can comprise a hydroxide, an alkoxide, a hydride, an aryl, an amide, an organic acid salt, or a combination comprising at least one of the foregoing.
  • the basic derivative of the metal can comprise sodium hydroxide, potassium hydroxide, lithium hydroxide, magnesium hydroxide, calcium hydroxide, strontium hydroxide, lithium hydride, sodium hydride, sodium methylate, sodium ethylate, sodium phenolate, sodium beta-naphtholate, sodamide, sodium stearate, lithium aluminium hydride, aluminium propylate, or a combination comprising at least one of the foregoing.
  • the catalyst can comprise sodium caprolactamate, such as CIO commercially available from BASF SE of Ludwigshafen, Germany.
  • the iminium salt can be prepared by adding the metal compound to the cyclic lactam monomer; or by first adding the metal compound to a portion of the cyclic lactam monomer and then adding the iminium salt to the remaining cyclic lactam monomer.
  • the lactam can be as anhydrous as the metal compound.
  • the catalyst can be present in an amount of 0.1 to 10 mol%, or 0.1 to 5 mol% based on the total moles of the lactam and catalyst.
  • the catalyst can be present in an amount of 1 to 6 wt% based on a total weight of the monomer, activator, and catalyst. The more catalyst added, the lower the molecular weight of the resultant polyamide.
  • the time used for the preparation of the catalyst depends upon the properties of the compounds employed, the quantity added, and the temperature chosen, and can generally be from a few seconds to several hours (hr).
  • the iminium salt can be prepared by reacting the lactam with the metal compound by heating at a temperature of 25 to 220 °C.
  • the monomer mixture can comprise an activator (also referred to as a co- catalyst).
  • the activator can comprise any compound that, in addition to the catalyst, brings about polymerization of the cyclic lactam monomer.
  • the activator can comprise a carbodiimide (such as ⁇ , ⁇ '- diisopropyl carbodiimide, N,N'-di-(o-tolyl)-carbodiimide, ⁇ , ⁇ '- dicyclohexyl carbodiimide, 2,2',6,6'-tetraisopropyl diphenyl carbodiimide, or poly-(2,2- diisopropyl)-p-phenylene carbodiimide), a blocked or unblocked isocyanate (such as diphenyl methane diisocyanate, hexamethylene diisocyanate, toluol diisocyanate, isophorone diisocyanate, m-xylidene diisocyanate,
  • the activator can comprise
  • the activator can comprise a multifunctional activator (such as poly(hexamethylene diisocyanate, poly[(phenyl isocyanate)-co-formaldehyde], methyl isocyanate bound to polystyrene, 1-adamentyl isocyanate, or a combination comprising at least one of the foregoing.
  • the activator can comprise a combination comprising at least one of the foregoing activators.
  • the activator can be present in an amount of 0.1 to 5 mol% based on the total moles of the cyclic lactam monomer.
  • the activator can be present in an amount of 1 to 4 wt% based on a total weight of the monomer, activator, and catalyst.
  • a molar ratio of the catalyst to the activator can be 0.5 to 2, or 0.8 to 1.2.
  • the activator can be added before, during, or after adding the catalyst.
  • the activator can be dissolved in a portion of the cyclic lactam monomer and the dissolved activator can be added as an activator mixture.
  • the catalyst can be dissolved in a portion of the cyclic lactam monomer and the dissolved catalyst can be added as a catalyst mixture.
  • the polymerization can be performed in an inert environment.
  • an inert gas such as nitrogen, argon, and a noble gas
  • nitrogen, argon, and a noble gas can be introduced onto the surface of the reaction mixture during the polymerization to prevent oxidation.
  • the polymerization can comprise polymerizing the reaction mixture in a batch reactor or in a mold.
  • the polymerization can comprise mixing the thermoplastic polymer and the cyclic lactam monomer with one of the catalyst and the activator to form a monomer mixture, increasing the temperature of the monomer mixture to a polymerization temperature, and adding the other of the catalyst and the activator to initiate polymerization and form the polyamide composition.
  • the polymerizing can comprise reaction injection molding.
  • Reaction injection molding can be useful in rapidly preparing cast articles of varying size and shape directly from the cyclic lactam monomer.
  • reaction injection molding can have advantages when used in the manufacture of large molded articles, because reaction injection molding or similar processes use high temperatures and high pressures for their operations. Therefore, simpler and lighter weight molds can be employed and faster cycles can often be obtained in the manufacture of large shaped articles.
  • the reaction injection molding can comprise injecting a single mixture comprising the cyclic lactam monomer, the thermoplastic polymer, the catalyst, and the activator into a mold; two or more mixtures can be mixed just prior to the injection molding; or the two or more mixtures can be simultaneously added to the mold during the injection molding.
  • a first mixture comprising the cyclic lactam monomer, the polymer, and one of the catalyst and the activator can be mixed with a second mixture comprising the other of the catalyst and the activator just prior to the injection molding and the combined mixture can be injected into a mold to form the article.
  • the polymerizing can comprise resin transfer molding.
  • a preform can be positioned in a cavity of a molding tool, the molding tool can be closed and monomer mixture can be introduced into the cavity.
  • the preform can comprise a resin transfer molding core with a fiber reinforcement material affixed to its outer surface.
  • Internal communication passages can extend within an interior of the core, a first and a second internal communication passage each having an inlet opening and a discharge opening can extend through an outer surface of the core.
  • the molding tool can have a first port and a second port. Fluid communication can be formed between the first port and the inlet opening of the first internal communication passage and between the second port and the discharge opening of the second internal communication passage.
  • the monomer mixture can be introduced into the cavity through the first port, to and through the inlet opening of the first internal communication passage.
  • the cavity can be vented through the discharge opening of the second internal communication passage, to and through the second port.
  • the monomer mixture can then be cured to provide a fiber reinforced polyamide composition.
  • the polyamide composition can comprise an additive.
  • the additive can comprise a filler (including glass fillers, ceramic or mineral fillers, or carbon fillers), an antioxidant, a blowing agent, a plasticizer, a colorant, or a combination comprising at least one of the foregoing.
  • the additive can comprise eicosane, triacontane, a paraffin wax, or a combination comprising at least one of the foregoing.
  • the additive can be present in an amount known in the art. For example, any additive (except filler) can be individually present in an amount of 0.01 to 5 wt%, based on the total weight of the polyamide composition. In general, the total amount of additives (except filler) does not total more than 10 wt% of the polyamide composition.
  • An article can comprise the polyamide composition.
  • the article can be used in transportation vehicles (including cars, trucks, trains, planes, boats, jet skis, snow mobiles, motorcycles, helicopters, and the like).
  • Thermogravi metric analysis (TGA) of the polyamide compositions was performed by increasing the temperature from 0 to 1,000 °C at a rate of 10 °C/min under a constant flow of nitrogen gas.
  • CLTE coefficient of linear thermal expansion
  • Example 1 anionic polymerization of ⁇ -caprolactam was carried out in a 20 milliliter (mL) glass vial under atmospheric pressure.
  • the monomer mixture comprising ⁇ - caprolactam and the C20 activator, was melt mixed at a temperature of 150 °C under constant stirring.
  • the polymerization was initiated upon addition of the CIO catalyst, where the monomer mixture comprised 94 wt% of the ⁇ -caprolactam, 2 wt% of the C20 activator, 4 wt% of the CIO catalyst; all based on the total weight of the monomer mixture.
  • Example 2-12 anionic polymerization of ⁇ -caprolactam was carried out in accordance with Example 1, except that an amount of a thermoplastic polymer was added to the monomer mixture and the CIO catalyst was added after the thermoplastic polymer fully dissolved in the monomer.
  • the same amounts of the ⁇ -caprolactam, the C20 activator, and the CIO catalyst as used in Example 1 were used and an amount of the thermoplastic polymer was added such that the resultant monomer mixture comprised a wt% of the thermoplastic polymer based on the total weight of the monomer mixture as shown in Tables 1 and 2.
  • Table 1 Table 1
  • FIG. 1 and FIG. 2 show that there is significant phase separation in the polyamide compositions comprising polystyrene and poly(phenylene oxide).
  • FIG. 1 shows that there are polystyrene domains on the order of tens of micrometers embedded in the polyamide
  • FIG. 2 shows the formation of two-phase domains as pointed out by the arrow comprising the phase separated poly(phenylene oxide) and the polyamide.
  • FIG. 3 and FIG. 4 show that there is little to no phase separation between the polyamide and poly(ether ether sulfone) and the poly( ether imide), respectively.
  • FIG. 7 For compositions comprising poly(ether ether sulfone) and in FIG. 8 for compositions comprising poly(ether imide).
  • FIG. 7 and FIG. 8 show that Examples 9 and 12 of the poly(ether ether sulfone) and the poly( ether imide) compositions, respectively both had an onset of degradation at 550 °C as compared to Example 1 comprising only the polyamide, which had an onset of degradation at only 300 °C.
  • Example 8 show that the polyamide compositions comprising poly(ether ether sulfone) or the poly(ether imide) had both an increased onset and an increased offset of degradation as a function of their concentration in the polyamide composition, indicating an increased thermal stability as compared to Example 1.
  • Examples 8 and 10 are reduced as compared to Example 1.
  • FIG. 9 further shows that the thermal expansion of Example 10 is less than that of Example 8. This further reduction in the thermal expansion of the composition comprising poly(ether imide) is in accordance with the higher Tg increase observed in DSC analysis.
  • Embodiment 1 A polyamide composition, comprising: an anionically polymerized polyamide; and a thermoplastic polymer.
  • a Hildebrand solubility factor of the anionically polymerized polyamide can be within 15% of a Hildebrand solubility factor of the thermoplastic polymer.
  • Embodiment 2 The polyamide composition of Embodiment 1, wherein the polyamide composition comprises 5 to 50 wt% of the thermoplastic polymer based on a total weight of the polyamide composition.
  • Embodiment 3 The polyamide composition of any one or more of the preceding embodiments, wherein the polyamide composition has a crystallinity of 20 to 45 wt% as determined using differential scanning calorimetry.
  • Embodiment 4 The polyamide composition of any one or more of the preceding embodiments, wherein the polyamide composition has a coefficient of linear thermal expansion that is less than a corresponding coefficient of linear thermal expansion of a comparison polyamide composition formed in the absence of the thermoplastic polymer.
  • Embodiment 5 The polyamide composition of any one or more of the preceding embodiments, wherein the polyamide composition has a coefficient of linear thermal expansion of less than HOxlO "5 °C _1 .
  • Embodiment 6 The polyamide composition of any one or more of the preceding embodiments, wherein the Hildebrand solubility factor of the anionically polymerized polyamide is within 10% of the Hildebrand solubility factor of the thermoplastic polymer.
  • Embodiment 7 The polyamide composition of any one or more of the preceding embodiments, wherein the Hildebrand solubility factor of the anionically polymerized polyamide is within 5% of the Hildebrand solubility factor of the thermoplastic polymer.
  • Embodiment 8 The polyamide composition of any one or more of the preceding embodiments, wherein the Hildebrand solubility factors of the thermoplastic polymer and of the anionically polymerized polyamide are each independently greater than or equal to 19 J 1/2 cm “ /2 , or 19 to 25 J 1/2 cm “ /2 .
  • Embodiment 9 The polyamide composition of any one or more of the preceding embodiments, wherein the Hildebrand solubility factors of the thermoplastic polymer and of the anionically polymerized polyamide are each independently greater than or equal to 20 J 1/2 cm “ /2 , or 20 to 24 J 1/2 cm “ /2 .
  • Embodiment 10 The polyamide composition of any one or more of the preceding embodiments, wherein the thermoplastic polymer comprises a poly(ether imide), a poly(ether ketone), a poly(ether ether ketone), a poly(ether ketone ketone), a poly(ether sulfone), a poly(ether ether sulfone), or a combination comprising at least one of the foregoing.
  • the thermoplastic polymer comprises a poly(ether imide), a poly(ether ketone), a poly(ether ether ketone), a poly(ether ketone ketone), a poly(ether sulfone), a poly(ether ether sulfone), or a combination comprising at least one of the foregoing.
  • Embodiment 1 1 The polyamide composition of any one or more of the preceding embodiments, wherein the thermoplastic polymer comprises a poly(ether imide), a poly(ether ether sulfone), or a combination comprising at least one of the foregoing.
  • Embodiment 12 The polyamide composition of any one or more of the preceding embodiments, wherein the anionically polymerized polyamide has a weight average molecular weight of 2,000 to 100,000 Daltons as measured by gel permeation chromatography based on polystyrene standards.
  • Embodiment 13 The polyamide composition of any one or more of the preceding embodiments, wherein the anionically polymerized polyamide is derived from a cyclic lactam monomer comprising ⁇ -propiolactam, ⁇ -butyrolactam, ⁇ -valerolactam, ⁇ - caprolactam, enantholactam, caprylolactam, laurolactam, ⁇ , ⁇ -dimethylpropiolactam, ⁇ , ⁇ - dimethylpropiolactam, amylolactam, or a combination comprising at least one of the foregoing.
  • a cyclic lactam monomer comprising ⁇ -propiolactam, ⁇ -butyrolactam, ⁇ -valerolactam, ⁇ - caprolactam, enantholactam, caprylolactam, laurolactam, ⁇ , ⁇ -dimethylpropiolactam, ⁇ , ⁇ - dimethylpropiolactam, amylol
  • Embodiment 14 The polyamide composition of any one or more of the preceding embodiments, wherein the anionically polymerized polyamide is derived from a cyclic lactam monomer comprising ⁇ -caprolactam.
  • Embodiment 15 The polyamide composition of any one or more of the preceding embodiments, wherein the polyamide composition further comprises an additional polymer different from the anionically polymerized polyamide and the thermoplastic polymer.
  • Embodiment 16 The polyamide composition of Embodiment 15, wherein the additional polymer comprises a polyacetal, a polyolefin, a polyacrylic, a polycarbonate, a polystyrene, a polyester, a second polyamide, a polyamideimide, a polyarylate, a
  • Embodiment 17 The polyamide composition of any one or more of the preceding embodiments, wherein the polyamide composition further comprises an additive.
  • Embodiment 18 A method of making any one or more of the preceding polyamide compositions, comprising: anionically polymerizing a monomer mixture comprising a cyclic lactam monomer, the thermoplastic polymer, a catalyst, and an activator to form the polyamide composition.
  • Embodiment 19 The method of Embodiment 18, wherein the cyclic lactam monomer comprises ⁇ -propiolactam, ⁇ -butyrolactam, ⁇ -valerolactam, ⁇ -caprolactam, enantholactam, caprylolactam, laurolactam, ⁇ , ⁇ -dimethylpropiolactam, ⁇ , ⁇ - dimethylpropiolactam, amylolactam, or a combination comprising at least one of the foregoing.
  • the cyclic lactam monomer comprises ⁇ -propiolactam, ⁇ -butyrolactam, ⁇ -valerolactam, ⁇ -caprolactam, enantholactam, caprylolactam, laurolactam, ⁇ , ⁇ -dimethylpropiolactam, ⁇ , ⁇ - dimethylpropiolactam, amylolactam, or a combination comprising at least one of the foregoing.
  • Embodiment 20 The method of Embodiment 19, wherein the cyclic lactam monomer comprises ⁇ -caprolactam.
  • Embodiment 21 The method of any one or more of Embodiments 18 to 20, wherein the monomer mixture comprises 5 to 50 wt% of the thermoplastic polymer dissolved in the monomer mixture prior to the anionically polymerizing.
  • Embodiment 22 The method of any one or more of Embodiments 18 to 21, wherein the monomer mixture comprises 1 to 6 wt% of the catalyst based on the total weight of the monomer mixture.
  • Embodiment 23 The method of any one or more of Embodiments 18 to 22, wherein the monomer mixture comprises 1 to 4 wt% of the activator based on the total weight of the monomer mixture.
  • Embodiment 24 The method of any one or more of Embodiments 18 to 23, wherein the anionically polymerizing comprises reaction injection molding or resin transfer molding the monomer mixture.
  • Embodiment 25 An article comprising the polyamide composition of any one or more of the preceding embodiments.
  • Embodiment 26 The article of Embodiment 25, wherein the article is for use in a transportation vehicle.
  • the disclosure can alternately comprise, consist of, or consist essentially of, any appropriate components herein disclosed.
  • the disclosure can additionally, or alternatively, be formulated so as to be devoid, or substantially free, of any components, materials, ingredients, adjuvants or species used in the prior art compositions or that are otherwise not necessary to the achievement of the function and/or objectives of the present disclosure.
  • compositions, methods, and articles can alternatively comprise, consist of, or consist essentially of, any ingredients, steps, or components herein disclosed.
  • the compositions, methods, and articles can additionally, or alternatively, be formulated, conducted, or manufactured so as to be devoid, or substantially free, of any ingredients, steps, or components not necessary to the achievement of the function or objectives of the present claims.
  • the notation " ⁇ 10%" means that the indicated measurement may be from an amount that is minus 10% to an amount that is plus 10% of the stated value.
  • test standards are the most recent standard in effect as of the filing date of this application, or, if priority is claimed, the filing date of the earliest priority application in which the test standard appears.
  • the endpoints of all ranges directed to the same component or property are inclusive of the endpoints, are independently combinable, and include all intermediate points and ranges. For example, ranges of "up to 25 wt%, or 5 to 20 wt%" is inclusive of the endpoints and all intermediate values of the ranges of "5 to 25 wt%,” such as 10 to 23 wt%, etc.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Polyamides (AREA)

Abstract

La composition polyamide de l'invention comprend, dans un mode de réalisation, un polyamide polymérisé par voie anionique; et un polymère thermoplastique. Dans un autre mode de réalisation, un procédé de fabrication d'une composition polyamide comprend la polymérisation anionique d'un mélange de monomères comprenant un monomère de lactame cyclique, un polymère thermoplastique, un catalyseur et un activateur pour former la composition polyamide. Le facteur de solubilité de Hildebrand du polyamide polymérisé par voie anionique peut se situer dans une fourchette de 15% du facteur de solubilité de Hildebrand du polymère thermoplastique.
PCT/US2018/023273 2017-03-22 2018-03-20 Compositions polyamide comprenant un polymère thermoplastique Ceased WO2018175386A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762474816P 2017-03-22 2017-03-22
US62/474,816 2017-03-22

Publications (1)

Publication Number Publication Date
WO2018175386A1 true WO2018175386A1 (fr) 2018-09-27

Family

ID=63586228

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2018/023273 Ceased WO2018175386A1 (fr) 2017-03-22 2018-03-20 Compositions polyamide comprenant un polymère thermoplastique

Country Status (1)

Country Link
WO (1) WO2018175386A1 (fr)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7740861B2 (en) * 2004-06-16 2010-06-22 University Of Massachusetts Drug delivery product and methods
US20120040185A1 (en) * 2010-08-13 2012-02-16 Kimberly-Clark Worldwide, Inc. Toughened Polylactic Acid Fibers
WO2017019979A1 (fr) * 2015-07-30 2017-02-02 University Of Massachusetts Compositions de résistance aux chocs modifiée, procédés pour les fabriquer et articles les comprenant

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7740861B2 (en) * 2004-06-16 2010-06-22 University Of Massachusetts Drug delivery product and methods
US20120040185A1 (en) * 2010-08-13 2012-02-16 Kimberly-Clark Worldwide, Inc. Toughened Polylactic Acid Fibers
WO2017019979A1 (fr) * 2015-07-30 2017-02-02 University Of Massachusetts Compositions de résistance aux chocs modifiée, procédés pour les fabriquer et articles les comprenant

Similar Documents

Publication Publication Date Title
KR970000487B1 (ko) 신규 폴리아미드류 및 이로부터 수득되는 물품
KR100355649B1 (ko) 폴리아마이드및당해폴리아마이드의제조방법및당해폴리아마이드를함유한조성물
CN113121817B (zh) 低吸水率的聚酰胺共聚物56ti及其制备方法和应用
KR101319663B1 (ko) 보강된 폴리아미드 조성물
CN103635510B (zh) 具有不同嵌段的支链聚酰胺
JP5837377B2 (ja) 摺動部材
CN104350086B (zh) 浇注型聚酰胺、其生产方法及其用途
KR20180043274A (ko) 충격 개질된 조성물, 이의 제조 방법 및 이를 포함하는 물품
JP2003286347A (ja) 鎖状熱可塑性樹脂およびその製造方法
KR102142733B1 (ko) 캐스트 폴리아미드의 제조를 위한 촉매, 상기 촉매의 제조 방법 및 그의 용도
WO2018175386A1 (fr) Compositions polyamide comprenant un polymère thermoplastique
US4590243A (en) Process for the preparation of nylon block polymers
US20160068679A1 (en) Polymerizable lactam composition containing a sulfonated polyaryl sulfone
WO2018175384A1 (fr) Compositions de polyamide cristallines poreuses
CN112322034A (zh) 一种耐黄变尼龙复合材料及其制备方法
US4581419A (en) Acyllactam functional materials
JP2013525584A (ja) Ｐａ−４１０を製造するための方法およびこの方法により得られるｐａ−４１０
CN112566961B (zh) 非晶性聚酰胺树脂的制造方法
CN103582628B (zh) 用于生产铸型聚酰胺的新型组合物
KR102831620B1 (ko) 강인화 pla를 위한 pla 및 pa를 포함하는 다중 블록 공중합체 및 이의 제조방법
JP3067861B2 (ja) ポリエステルグラフト化ポリアミドおよびその製造法
JPH0124404B2 (fr)
US4645800A (en) Acyllactam functional materials
JPH04202527A (ja) 中空成形品の製造方法
JPH10287807A (ja) ポリエステルアミド樹脂組成物

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 18771471

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 18771471

Country of ref document: EP

Kind code of ref document: A1